TIDES USA is the flagship must-attend event in the TIDES: Oligonucleotide & Peptide Therapeutics portfolio. It is the world’s largest gathering for those interested in accelerating oligonucleotide, peptide, mRNA and genome editing products from early discovery to late-stage development and commercialization.
The program features 4 concurrent tracks covering the following 6 scientific themes including in-depth development strategies, trends, and technologies across the entire spectrum of oligonucleotides, peptides, mRNA, and genome editing.
TIDES USA 2022 TRACKS:
- Oligonucleotide Chemistry, Manufacturing & Controls
- Oligonucleotide Discovery, Preclinical and Clinical
- Peptide Chemistry, Manufacturing & Controls
- Peptide Discovery, Preclinical and Clinical
- mRNA Therapeutics/Vaccines & Genome Editing
- Drug Delivery Innovations
Founded in 2015, Hzymes Biotechnology Co., Ltd. (Enzymes) is a high-tech enterprise specializing in the research and development, production, application and technical services of enzymes.